Document is current

Article History

First Online: 20 June 2025

Disclosure

: Dr. Michelle M. Dugan, Aleena Boby, Helana Ghali, Shaliz Aflatooni, Dr. Danielle K. DePalo, Dr. Anne Huibers, and Wenyi Fan have no conflicts of interest or financial ties to disclose. Dr. Roger Olofsson Bagge has received institutional research grants from Bristol-Myers Squibb (BMS), Endomagnetics Ltd (Endomag), and SkyLineDx; has received speaker honorarium from Roche, Pfizer, and Pierre-Fabre; has served on advisory boards for Amgen, BD/BARD, Bristol-Myers Squibb (BMS), Merck Sharp and Dohme (MSD), Novartis, Roche, and Sanofi Genzyme; and is a shareholder in SATMEG Ventures AB. Dr. Jonathan S. Zager has received payments from Delcath Systems—Medical Advisory Board. He has received fees from Philogen, Merit Medical, Castle Biosciences, Menarini Silicon Biosystems, Replimune, and Merck and declares High flow ILI US patent. His department receives research funding from Philogen, SWOG, Delcath Systems, and Provectus. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.